Here is Wednesday’s biggest call on Wall Street: Bernstein started Iris Energy and Scientific Core as outperform Bernstein said he was bullish on some bitcoin miners on Monday night. “We extended our Bitcoin equity coverage to two additional Bitcoin miners with a hybrid Bitcoin/AI data center strategy. We started on IREN ($26, 78% up) and CORZ ($17, 64% up) with Outperform.” Argus upgrades Teva to buy from hold Argus says the pharmaceutical company has a strong pipeline. “Upgraded to BUY. After years of challenges, Teva appears to have steadied the ship, launching multiple new drugs and achieving margin growth in all three key business segments.” Piper Sandler downgraded Target to neutral from overweight Piper downgraded the stock after a change in analyst coverage. “We like TGT’s strong omni-channel model and believe the company has exceptional merchandising capabilities. a catalyst we can see driving sales/margins above near-term estimates.” Jefferies reiterates Walmart as the top choice Jefferies says it remains with Walmart as the top idea. “We continue to believe that the company is on the cusp of a $20B+ EBIT growth opportunity and show below some of the latest developments that include a partnership with Fox Robotics and Sam’s Clubs arch technology. WMT remains our top pick.” Redburn Atlantic Equities downgrades Spotify to sell from neutral Redburn said the growth prospects are very bullish. “While Spotify’s operating momentum has been impressive, the consensus is that the growth forecast is too much. We downgrade to Sell, with a 27% downside to our price target of $230. Jefferies reiterates Oracle as a buy. Jefferies says it remains with a buy rating ahead of earnings later this quarter.” All eyes will be on Q August, and we believe ORCL can continue to track to $ 65B rev / 45% opm in FY26 Goldman Sachs reiterates Tesla as neutral Goldman said it stands by the neutral rating on Tesla shares. “We maintain a Neutral rating on the stock, and increase the 12-month price target to $ 248 from $ 175, which is currently based on 65X applied to update Q5-Q8E EPS Barclays reiterates Eli Lilly as a concern Barclays raised its stock price target to $ 1,025 from $ 913 ” A combination of steps in the Mounjaro / Zepbound script trend, continued messaging about supplies coming online in 2H, narratives strengthening clinical catalysts on the horizon, and signs of new momentum. in the non-metabolic portfolio should continue to raise the LLY stocks higher. “Accelerating AI Growth & Leadership Undervalued.” Citi upgrades Quest Diagnostics to buy from neutral Citi says it likes the lab diagnostics company’s prospects. “We upgrade … DGX from Neutral to Buy (PT from $ 145 to $ 165) in the potential up to the number.” Bank of America initiates MKS Instruments as buyout Bank of America says it sees earnings per share rising for the measurement and control equipment manufacturing company. “Initiate coverage on MKS Instruments with Buy and $160 PO, based on 14x CY25E EV/EBITDA, inline with peers.” Needham upgrades Carvana to buy from hold Needham said he sees “profitable growth ahead” for Carvana shares. “We think CVNA can grow unit sales and industry share by leveraging a digital-first customer experience and underutilized physical footprint.” BTIG started J.Jill as a buyer BTIG said shares of clothing stores are compelling. “We see the story of JILL as attractive given the ability to take part of a large, underserved market where the competitive landscape has become less intense, suggesting opportunities as the improvement of execution under renewed leadership continues to take hold…” Citi opens trading pairs in Alaska and Southwest Citi said it was concerned about summer disruptions for Southwest. “Citi opened a pair of trades, choosing Alaska which is rated Buy over Southwest Airlines which is rated Neutral. TD Cowen declared Amazon as a buy. TD Cowen raised its price target on the stock to $245 per share from $225 before this month’s earnings. “We Expect AMZN To Reports 2Q24 Results Ahead of Consensus.” TD Cowen Says Alphabet as a Buy TD Cowen Raises Price Target on Alphabet to $220 per Share from $200. Again Meta as Buy TD Cowen Raises Price Target on Meta to $600 per Share from $530 “Multiple Near Term, AI Supported Growth Drivers at Play.” limited upside” for payment stocks. “While we maintain a favorable view on V/MA’s premier business model and competitive moat, we see limited upside potential for some valuations and estimates. “Bank of America downgrades WK Kellogg to underperform from neutral Bank of America said it sees weakening industrial trends for WK Kellogg . “Volume trends in the packaged food industry (and cereal in particular) have not shown significant improvement despite expectations that SNAP (supplemental nutrition assistance program) and a more promotional environment will lead to volume increases. KeyBanc says Netflix is ​​overweight. Key raises target price in the stock to $ 735 per share from $ 707 “We believe that Netflix’s upcoming 2Q earnings print will strengthen: 1) the net increase remains strong to a strong content slate (for example, NFL, Squid Game, Night Agent, Cobra Kai. all is set to 2H24E); and 2) monetization initiatives.” Needham reaffirmed Apple when buying Needham raised his price target on the stock to $260 per share from $220. the company is spending $50-$100B on GenAI infrastructure instead.” Truist started Fluence as a buy Truist says the energy storage company is well positioned. Fluence is also positioned to drive greater growth through better economies of scale/differentiated supply chain & technology positions.” Truist rates Nvidia as a buy Truist says it maintains a buy rating on the stock. “Expect NVDA to be #1- er the old way: earnings growth, through organic sales growth. partly offset by its strength in liquid cooling. “We initiate coverage of Bausch + Lomb (BLCO) with an Outperform rating and a $19 price target.” Bank of America started Composecure as a buy Bank of America said it is bullish on the shares of the manufacturer of metal payment cards. “We initiate coverage of premium metal card issuer Composecure (CMPO) with a Buy rating and $9 PO.”